Research Site

Remscheid 42859

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small Cell Lung, Crohn's Disease, Eosinophilic Esophagitis, IBD

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• A Study of Benralizumab in Patients With Eosinophilic Esophagitis — Stopped early